Viewing Study NCT02796261


Ignite Creation Date: 2025-12-24 @ 12:03 PM
Ignite Modification Date: 2026-01-02 @ 3:01 AM
Study NCT ID: NCT02796261
Status: UNKNOWN
Last Update Posted: 2022-01-21
First Post: 2016-06-03
Is Gene Therapy: True
Has Adverse Events: False

Brief Title: Study to Evaluate Eflornithine + Lomustine vs Lomustine in Recurrent Anaplastic Astrocytoma (AA) Patients
Sponsor: Orbus Therapeutics, Inc.
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module References Module